201 related articles for article (PubMed ID: 9924159)
1. Economic impact on physicians and hospitals of proposed changes in Medicare reimbursement for coronary interventions.
Vaitkus PT
Am Heart J; 1999 Feb; 137(2):258-63. PubMed ID: 9924159
[TBL] [Abstract][Full Text] [Related]
2. The impact of reimbursement changes for intracoronary stents on providers and Medicare.
Vaitkus PT
Am J Manag Care; 1998 Aug; 4(8):1097-102. PubMed ID: 10182885
[TBL] [Abstract][Full Text] [Related]
3. Economic impact of drug-eluting stents on hospital systems: a disease-state model.
Kong DF; Eisenstein EL; Sketch MH; Zidar JP; Ryan TJ; Harrington RA; Newman MF; Smith PK; Mark DB; Califf RM
Am Heart J; 2004 Mar; 147(3):449-56. PubMed ID: 14999193
[TBL] [Abstract][Full Text] [Related]
4. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
[TBL] [Abstract][Full Text] [Related]
5. Economic outcomes analysis of stenting versus percutaneous transluminal coronary angioplasty for patients with coronary artery disease in Japan.
Ikeda S; Bosch J; Banz K; Schneller P
J Invasive Cardiol; 2000 Apr; 12(4):194-9. PubMed ID: 10785672
[TBL] [Abstract][Full Text] [Related]
6. Clinical and economic outcomes of multivessel coronary stenting compared with bypass surgery: a single-center US experience.
Reynolds MR; Neil N; Ho KK; Berezin R; Cosgrove RS; Lager RA; Sirois C; Johnson RG; Cohen DJ
Am Heart J; 2003 Feb; 145(2):334-42. PubMed ID: 12595853
[TBL] [Abstract][Full Text] [Related]
7. Paradigm shifts in cardiovascular medicine.
Holmes DR; Firth BG; Wood DL
J Am Coll Cardiol; 2004 Feb; 43(4):507-12. PubMed ID: 14975455
[TBL] [Abstract][Full Text] [Related]
8. Medical economic considerations of coronary stenting.
Szucs TD
Schweiz Med Wochenschr; 1999 Nov; 129(45):1701-11. PubMed ID: 10595380
[TBL] [Abstract][Full Text] [Related]
9. Physician payment 2008 for interventionalists: current state of health care policy.
Manchikanti L; Giordano J
Pain Physician; 2007 Sep; 10(5):607-26. PubMed ID: 17876359
[TBL] [Abstract][Full Text] [Related]
10. [Coronary angioplasty in elderly patients].
Liistro F; Colombo A
Ital Heart J Suppl; 2002 Jan; 3(1):1-8. PubMed ID: 11899566
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the institutional volume-outcome relations for balloon angioplasty and stenting in the stent era in California.
Brown DL
Am Heart J; 2003 Dec; 146(6):1071-6. PubMed ID: 14661001
[TBL] [Abstract][Full Text] [Related]
12. Direct coronary stenting compared with stenting after predilatation is feasible, safe, and more cost-effective in selected patients: evidence to date indicating similar late outcomes.
Ijsselmuiden AJ; Tangelder GJ; Cotton JM; Vaijifdar B; Kiemeneij F; Slagboom T; v d Wieken R; Serruys PW; Laarman GJ
Int J Cardiovasc Intervent; 2003; 5(3):143-50. PubMed ID: 12959731
[TBL] [Abstract][Full Text] [Related]
13. Economic impact of angioplasty salvage techniques, with an emphasis on coronary stents: a method incorporating costs, revenues, clinical effectiveness and payer mix.
Vaitkus PT; Witmer WT; Brandenburg RG; Wells SK; Zehnacker JB
J Am Coll Cardiol; 1997 Oct; 30(4):894-900. PubMed ID: 9316515
[TBL] [Abstract][Full Text] [Related]
14. Comparing angiographic coronary revascularization strategies: a 'natural' experiment.
Kassam S; Goel V; Lazzam C; Detsky AS
Can J Cardiol; 2000 Mar; 16(3):337-44. PubMed ID: 10744797
[TBL] [Abstract][Full Text] [Related]
15. The impact of general usage of stents on short- and long-term health care costs following percutaneous coronary intervention.
Odell A; Landelius P; Astrom-Olsson K; Grip L
Cardiology; 2008; 109(2):85-92. PubMed ID: 17664872
[TBL] [Abstract][Full Text] [Related]
16. Comparison of primary balloon angioplasty with bailout stenting strategy to primary coronary stenting strategy in the treatment of patients with ST-segment elevation myocardial infarction (STEMI).
Tajstra M; Gasior M; Lekston A; Wilczek K; Hawranek M; Gierlotka M; Słonka G; Zebik T; Poloński L
Kardiol Pol; 2007 Nov; 65(11):1277-84; discussion 1285-6. PubMed ID: 18058578
[TBL] [Abstract][Full Text] [Related]
17. The implications of reimbursement changes for specialty hospitals.
Zimmerman E
Healthc Financ Manage; 2006 Jul; 60(7):42-5. PubMed ID: 16869322
[TBL] [Abstract][Full Text] [Related]
18. Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] Trial): immediate and long-term results.
Rodriguez AE; Rodriguez Alemparte M; Fernandez Pereira C; Vigo CF; Sampaolesi A; Bernardi V; Marchand E; Tronge J; Palacios IF;
Am Heart J; 2005 Jul; 150(1):188. PubMed ID: 16086559
[TBL] [Abstract][Full Text] [Related]
19. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.
Bakhai A; Stone GW; Mahoney E; Lavelle TA; Shi C; Berezin RH; Lahue BJ; Clark MA; Lacey MJ; Russell ME; Ellis SG; Hermiller JB; Cox DA; Cohen DJ;
J Am Coll Cardiol; 2006 Jul; 48(2):253-61. PubMed ID: 16843171
[TBL] [Abstract][Full Text] [Related]
20. Commentary on the reimbursement paradox.
Reaven NL; Rosenbloom J
Crit Care Med; 2009 Jul; 37(7 Suppl):S285-9. PubMed ID: 19535960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
